3. Subject to article 6, the following descriptions and classes of medicinal products are specified for the purposes of section 58, namely–
(a)medicinal products consisting of or containing a substance listed in column 1 of Schedule 1;
(b)medicinal products that are controlled drugs;
(c)medicinal products that are for parenteral administration, other than preparations of insulin for parenteral administration;
(d)cyanogenetic substances, other than preparations for external use;
(e)medicinal products that on administration emit radiation, or contain or generate any substance which emits radiation, in order that radiation may be used;
(f)medicinal products for human use which are classified as subject to medical prescription in marketing authorizations granted under Council Regulation 2309/93(1);
(g)medicinal products–
(i)which are not of a description and do not fall within a class specified in subparagraphs (a) to (f),
(ii)which are of a description in respect of which the conditions specified in section 59(1) are satisfied, and
(iii)in respect of which a product licence or marketing authorization has been granted which contains a provision to the effect that the method of sale or supply of the medicinal product is to be only in accordance with a prescription given by an appropriate practitioner.
OJ No. L214, 24.8.93, p. 1.